Chin imperfections: our experience with botulinum toxin A Botulinum toxin in the chin

Main Article Content

Bartolo Corradino
Sara Di Lorenzo
Anna Corradino
Andrea Pio Cascino

Keywords

Chin, botulinum, wrinkles

Abstract

The chin is a highly complex structure from an anatomical and functional point of view, and the imperfections that arise are difficult to treat. We propose an innovative, infiltrative technique to correct the dimpling of the chin using botulinum toxin. The outcome of this procedure produced minimal side effects and optimal aesthetic results. The study consisted of 12 patients who were photographed before and after administering the botulinum toxin, and were asked to assess their degree of satisfaction of the final results. The satisfaction score was relatively high considering 100% of the patients reported as an adverse effect the loss of expressiveness, and each knew that they would have to repeat the procedure for a continued result.

Abstract 272 | PDF Downloads 504

References

1. Chen B, Ma L, Wang J. Chin Augmentation With Hyaluronic Acid: An Injection Technique Based on Anatomical Morphology. Dermatol Surg. 2022; 48(7):747-751.
2. D’Souza A, Chew Lip Ng. Applied Anatomy for Botulinum Toxin Injection in Cosmetic Interventions. Current Otorhinolaryngology Reports. 2020; 8:336-343.
3. Schuenke, M. S. E. S. U. Prometheus: Atlante di Anatomia. (2019).
4. Hsu AK, Frankel AS. Modification of Chin Projection and Aesthetics With OnabotulinumtoxinA Injection. JAMA Facial Plast Surg. 2017; 19(6):522–527.
5. Gart MS, Gutowski KA. Aesthetic Uses of Neuromodulators. Plastic Reconstr Surg. 2015; 136(5 Suppl):62S-71S.
6. Corradino B, Di Lorenzo S, Mossuto C, Costa RP, Moschella F. Botulinum toxin in preparation of oral cavity for microsurgical reconstruction. Acta Otolaryngol. 2010; 130(1):156-160.
7. World Medical Association. World Medical Association Declaration of Helsinki: Ethical principles for medical research involving human subjects. JAMA. 2013; 310(20):2191–2194.
8. Klassen AF, Cano SJ, Scott A, Snell L, Pusic AL. Measuring patient-reported outcomes in facial aesthetic patients: development of the FACE-Q. Facial Plast Surg. 2010; 26(24):303–9.
9. Ascher B, Rzany B, Kestemont P, et al. Significantly Increased Patient Satisfaction Following Liquid Formulation AbobotulinumtoxinA Treatment in Glabellar Lines: FACE-Q Outcomes From a Phase 3 Clinical Trial. Aesthet Surg J. 2020; 40(9):1000-1008.
10. Chang BL, Wilson AJ, Taglienti AJ, Chang CS, Folsom N, Percec I. Patient Perceived Benefit in Facial Aesthetic Procedures: FACE-Q as a Tool to Study Botulinum Toxin Injection Outcomes. Aesthet Surg J. 2016; 36(7):810–20.
11. Klassen AF, Cano SJ, Schwitzer JA, Scott AM, Pusic AL. FACE-Q scales for health-related quality of life, early life impact, satisfaction with outcomes, and decision to have treatment: development and validation. Plast Reconstr Surg. 2015; 135(2):375–386.
12. Ascher B, Talarico S, Cassuto D, et al. International consensus recommendations on the aesthetic usage of botulinum toxin type A (Speywood Unit) - part II: wrinkles on the middle and lower face, neck and chest. J Eur Acad Dermatol Venereol. 2010; 24(11):1285–1295.
13. de Maio M, Wu WTL, Goodman GJ, Monheit G, Alliance for the Future of Aesthetics Consensus Committee. Facial Assessment and Injection Guide for Botulinum Toxin and Injectable Hyaluronic Acid Fillers: Focus on the Lower Face. Plast Reconstr Surg. 2017; 140(3):393e–404e.
14. Beer K, Yohn M, Closter J. A double-blinded, placebo-controlled study of Botox for the treatment of subjects with chin rhytids. J Drugs Dermatol. 2005; 4(4):417–22.
15. Lorentz I. Treatment of hemifacial spasm with botulinum toxin. J Clin Neurosci. 1995; 2(2):132–135.
16. Devetag Chalaupka F, Bartholini F, Mandich G, Turro M. Two new families with hereditary essential chin myoclonus: clinical features, neurophysiological findings and treatment. Neurol Sci. 2006; 27(2):97–103.